HIGHLIGHTS
- who: Wenke Cheng and colleagues from the Department of Internal Medicine/Cardiology, Heart Center Leipzig at University of Leipzig, Leipzig, Germany have published the research work: Circulating Galectin-3 in Patients with Cardiogenic Shock Complicating Acute Myocardial Infarction Treated with Mild Hypothermia: A Biomarker Sub-Study of the SHOCK-COOL Trial, in the Journal: (JOURNAL)
- what: The present biomarker study aimed to elucidate the effect of MTH on Gal-3 in patients with CS as the most severe form of acute decompensated heart failure. The aim of this study was to compare the differences in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.